Chorea and retinal vessel occlusion in a patient with systemic lupus erythematosus

Vahid-Reza Ostovan1, Askar Ghorbani

  • 1Department of Neurology, Shariati Hospital, Tehran University of Medical Sciences AND Iranian Center of Neurological Research, Tehran, Iran.

Insights

This case report details a patient with antiphospholipid syndrome (APS) and systemic lupus erythematosus (SLE) who experienced both chorea and retinal vessel occlusion. These rare, co-occurring neurological complications highlight the diverse manifestations of APS and SLE.

Area of Science:

  • Neurology
  • Rheumatology
  • Ophthalmology

Background:

  • Antiphospholipid syndrome (APS) is an autoimmune disorder associated with aPL antibodies, leading to various neurological complications.
  • Systemic lupus erythematosus (SLE) can also present with neurological issues, and its association with APS is well-documented.

Observation:

  • A 27-year-old male presented with involuntary movements (chorea), slurred speech, and vision loss in his right eye.
  • Clinical investigations confirmed the diagnoses of both SLE and APS.

Findings:

  • The patient exhibited concomitant chorea and retinal vessel occlusion, a rare combination of neurological and ocular manifestations.
  • Treatment involved anticoagulants and immunosuppressants, including prednisolone, leading to clinical improvement.

Implications:

  • This case underscores the importance of recognizing the diverse and sometimes overlapping neurological manifestations of SLE and APS.
  • The co-occurrence of retinal vessel occlusion and chorea in this patient provides valuable insight into the complex pathophysiology of these conditions.
  • Early diagnosis and comprehensive treatment are crucial for managing patients with combined SLE and APS to prevent severe complications.

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
65
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
8.5K
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
773
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
422